Agnos Therapeutics

Private

Baltimore, MarylandHealthcare & Life Scienceshttps://agnostx.com/

Last Round

VC Round

Jan 29, 2026

Company Overview

Agnos Therapeutics is a biotechnology company developing mutation-agnostic, iPSC-derived retinal cell therapies to restore vision for patients with inherited blindness.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cell therapyinherited retinal diseasesIRDinduced pluripotent stem celliPSCregenerative medicinemutation-agnostic therapyoff-the-shelf therapybiotechretinal cell therapydrug discoveryblindness treatmentallogeneic cell therapyclinical-stage biopharmaorphan drug

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Agnos Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Agnos Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Agnos Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Jan 29, 2026
Pre Seed	Jun 10, 2025
Grant	May 14, 2024

View all Funding Rounds

Agnos Therapeutics Investors

Notable investors and investment history

Agnos Therapeutics investors
Investor	Rounds
Johns Hopkins Technology Ventures	Pre Seed
Maryland Stem Cell Research Fund	Grant

View all Investors

Agnos Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Agnos Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Agnos Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland

Employee Range3

Year Founded2025

Last FundingJan 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.